4//SEC Filing
GOLDFISCHER CARL 4
Accession 0000899243-20-030917
CIK 0001571498other
Filed
Nov 12, 7:00 PM ET
Accepted
Nov 13, 7:05 AM ET
Size
6.5 KB
Accession
0000899243-20-030917
Insider Transaction Report
Form 4
Epizyme, Inc.EPZM
GOLDFISCHER CARL
Director10% Owner
Transactions
- Purchase
Common Stock, par value $0.0001
2020-11-11$12.07/sh+5,000$60,350→ 5,000 total
Holdings
- 3,380,951(indirect: See Footnote)
Common Stock, par value $0.0001
Footnotes (2)
- [F1]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $11.98 per share to $12.10 per share, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
- [F2]Represents shares of common stock held by entities affiliated with Bay City Capital, LLC including Bay City Capital Fund V, L.P. and Bay City Capital Fund V Co-Investment Fund, L.P. Bay City Capital Management V LLC ("GP V") is the general partner of Bay City Capital Fund V, L.P. and Bay City Capital Fund V Co-Investment Fund, L.P. (collectively, "BCC V"). Bay City Capital, LLC ("BCC LLC") is the manager of GP V. The Reporting Person is an investment partner and managing director of BCC LLC and shares voting and dispositive power with respect to shares held by BCC V. The Reporting Person disclaims beneficial ownership of these shares, except to the extent of any pecuniary interest therein.
Documents
Issuer
Epizyme, Inc.
CIK 0001571498
Entity typeother
Related Parties
1- filerCIK 0001110780
Filing Metadata
- Form type
- 4
- Filed
- Nov 12, 7:00 PM ET
- Accepted
- Nov 13, 7:05 AM ET
- Size
- 6.5 KB